Variation in the use of recombinant activated factor VII in critical bleeding

Internal Medicine Journal

Volumn 40, Issue 7, 2010, Pages 486-493

  Willis, C D ^a   Cameron, P A ^a   Phillips, L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

dosage; factor VIIa; haemorrhage; haemostasis; novoseven

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; AUSTRALIA; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CRITICALLY ILL PATIENT; CRYOPRECIPITATE; DEEP VEIN THROMBOSIS; ERYTHROCYTE; FEMALE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEART SURGERY; HEMOSTASIS; HOSPITAL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER SURGERY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; SURVIVAL RATE; THROMBOCYTE; THROMBOCYTE COUNT; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE;

ADULT; AGED; AUSTRALIA; DRUG UTILIZATION; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; OFF-LABEL USE; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 77954654256     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02044.x     Document Type: Article

References (20)

1. Charles A, Shaikh AA, Walters M, Huehl S, Pomerantz R. Blood transfusion is an independent predictor of mortality after blunt trauma. Am Surg 2007 73 : 1 5.
2. Scott BH, Seifert FC, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth 2008 11 : 15 19.
3. Jeffers L, Chalasani N, Balart L, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 2002 123 : 118 126.
4. Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, González Abraldes J et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004 127 : 1123 1130.
5. Pihusch M, Bacigalupo A, Szer J, von Depka Prondzinski M, Gaspar-Blaudschun B, Hyveled L et al. Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost 2005 3 : 1935 1944.
6. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008 358 : 2127 2137.
7. Raivio P, Suojaranta-Ylinen R, Kuitunen AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 2005 80 : 66 71.
8. Karkouti K, Yau TM, Riazi S, Dattilo KM, Wasowicz M, Meineri M et al. Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery. Can J Anaesth 2006 53 : 802 809.
9. Bishop CV, Renwick WEP, Hogan C, Haeusler M, Tuckfield A, Tatoulis J. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg 2006 81 : 875 879.
10. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005 95 : 596 602.
11. Tritapepe L, De Santis V, Vitale D, Nencini C, Pellegrini F, Landoni G et al. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis. Crit Care Med 2007 35 : 1685 1690.
12. Vincent J-L, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective. Crit Care 2006 10 : R120.
13. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008 48 : 12 16.
14. McCall P, Story DA, Karapillai D. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery. Can J Anaesth 2006 53 : 926 933.
15. Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J, Cameron P. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register. Intern Med J 2008 38 : 156 165. (Pubitemid 351271402)
16. Johnson SJ, Ross MB, Moores KG. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery. Am J Health Syst Pharm 2007 64 : 1808 1812.
17. Goodnough LT, Lublin DM, Zhang L, Despotis G, Eby C. Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion 2004 44 : 1325 1331.
18. Labattaglia MP, Ihle B. Recombinant activated factor VII: current perspectives and Epworth experience. Heart Lung Circ 2007 16 (Suppl 3 S96 101.
19. Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg 2008 248 : 61 8.
20. Sharma OP, Oswanski MF, Joseph RJ, Tonui P, Westrick L, Raj SS et al. Venous thromboembolism in trauma patients. Am Surg 2007 73 : 1173 1180.